Details
Description
In this report, we examined utilization patterns of baloxavir and oseltamivir for prophylaxis and treatment of influenza. The study period includes data from October 24, 2018 to March 31, 2022. We executed this request on Merative™ MarketScan® Research Databases on March 2, 2023.